High-dose methotrexate for elderly patients with primary CNS lymphoma-Reference-Cited by-同舟云学术

High-dose methotrexate for elderly patients with primary CNS lymphoma

Published:2009-04-01 Issue:2 Volume:11 Page:211-215
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Zhu Jay-Jiguang,Gerstner Elizabeth R.,Engler David A.,Mrugala Maciej M.,Nugent Whitney,Nierenberg Kristin,Hochberg Fred H.,Betensky Rebecca A.,Batchelor Tracy T.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/11/2/211/13065543/16_NO07-00248_Gerstner.pdf

Reference23 articles.

1. Rubenstein J, Fridlyand J, Shen A, et al. Gene expression and angiotropism in primary CNS lymphoma. Blood. 2006;107: 3716-3723.

2. Ferreri AJ, Reni M, Pasini F, et al. A multicenter study of treatment of primary CNS lymphoma. Neurology. 2002;58: 1513-1520.

3. Ferreri A, Blay J, Reni M, et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol. 2003;21: 266-272.

4. Abrey LE, Ben-Porat L, Panageas KS, et al. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. J Clin Oncol. 2006;24: 5711-5715.

5. Plotkin SR, Batchelor TT. Primary nervous-system lymphoma. Lancet Oncol. 2001;2: 354-365.

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma;British Journal of Haematology;2024-08-05

2. Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial;The Lancet Healthy Longevity;2024-03

3. Rare CNS Metastasis from Peripheral T Cell Lymphoma;psychopraxis. neuropraxis;2023-12-28

4. Evidence-based management of primary and secondary CNS lymphoma;Seminars in Hematology;2023-12

5. Central Nervous System Lymphoma;Seminars in Neurology;2023-11-23